颞浅筋膜瓣包裹高密度聚乙烯-肋软骨复合支架一期耳廓再造术

目的探寻耳廓再造的良好手术方法。方法将高密度聚乙烯耳基架与肋软骨外耳轮形成复合支架，支架采用颞浅筋膜瓣包裹，颞浅筋膜瓣的表面采用邻近皮瓣和皮片覆盖，完成耳廓再造。结果自2000年1月至2003年8月利用该方法对8例先天性小耳进行耳廓再造术效果良好。结论通过该方法行耳廓再造，具备良好的外形和一定的弹性，外观逼真，手感良好。     

小耳畸形残耳软骨的生物化学研究

目的　探讨正常耳软骨与先天性小耳畸形的残耳软骨生化成分的异同 ,进而推论小耳畸形的病因。方法　选取年龄在 10岁左右 ,Tanzer分类ⅡA型的 7例先天性小耳畸形患者的残耳软骨 (A组 )。同时取 7名同龄尸体的正常耳廓耳甲部分的软骨 (B组 )。各取 7份标本做生化检查 ,测定胶原、糖胺多糖 (glycoaminoglycan ,GAG)含量 ;硫酸软骨素 (chondroitinsulfate,Chs)、硫酸角质素 (keratansulfate ,KS)和透明质酸 (hyaluronan ,HA)各占GAG的百分含量。结果　A组与B组之间胶原含量差异无显著性意义 ;GAG含量差异有显著性意义A组 (49.0 0± 2 5 .6 0 ) μg/mg比B组 (2 8.2 5± 4 .80 ) μg/mg多。在GAG中的组成部分中 ,A组HA(38.96± 4 .97) %、Chs(2 9.0 2± 4 .12 ) %、KS(32 .16± 7.4l) %与B组HA(32 .94± 3.2 4 ) %、Chs(33.10± 2 .6 1) %、KS(33.96± 1.6 6 ) %之间HA和Chs含量差异有显著性意义 ,而KS含量差异无显著性意义。结论　残耳软骨与正常耳软骨中胶原含量无差异 ,但含GAG前者比后者多。在GAG中的各成分的百分含量中 ,残耳软骨含HA较高 ,Chs较低 ,KS与正常耳软骨无差异。     

Anatomic Variants on Computed Tomography in Congenital Aural Atresia and Stenosis

Objectives

To quantitatively analyzing the anatomic variants on temporal computed tomography (CT) in congenital external auditory canal stenosis (EACS), congenital aural atresia (CAA), and normal ear structure.

Methods

Through a retrospective study, we analyzed 142 temporal high-resolution CT studies performed in 71 microtia patients. The following 6 parameters were compared among the three groups: Marx classification, medial canal diameter, vertical facial nerve (VFN) anterior displacement, tegmen mastoideum position, tympanic cavity volume, and malleus-incus joint or malleus-incus complex (MIC) area.

Results

The results showed that the microtia distributions in the Marx classification in these three groups were significantly different, as 86% (31 of 35) of ears with major microtia (third-degree dysplasia) had an atresia, and in 54.8% (23 of 42) of the minor microtic (first-degree or second-degree) ears, the bony or cartilaginous part of the external auditory canal was stenotic. Measurement data also showed that the potential medial canal diameter of the atresia group was obviously shorter than that of the stenosis group. The VFN anterior displacement and temporomandibular joint backward-shift together lead to medial canal diameters in ears with atresic canals that is smaller than those with stenotic canals. The tegmen mastoideum position was not significantly different between the three groups.

Conclusion

The mal-development of the external auditory canal is significantly associated with auricle and middle ear developmental anomalies. Compared with CAA ears, EACS have better development of the auricle, canal, tympanic cavity and MIC and relatively safer surgical operation except for the position of the tegmen mastoideum and the VFN.     

Regeneration of human-ear-shaped cartilage by co-culturing human microtia chondrocytes with BMSCs

Previously, we had addressed the issues of shape control/maintenance of in vitro engineered human-ear-shaped cartilage. Thus, lack of applicable cell source had become a major concern that blocks clinical translation of this technology. Autologous microtia chondrocytes (MCs) and bone marrow stromal cells (BMSCs) were both promising chondrogenic cells that did not involve obvious donor site morbidity. However, limited cell availability of MCs and ectopic ossification of chondrogenically induced BMSCs in subcutaneous environment greatly restricted their applications in external ear reconstruction. The current study demonstrated that MCs possessed strong proliferation ability but accompanied with rapid loss of chondrogenic ability during passage, indicating a poor feasibility to engineer the entire ear using expanded MCs. Fortunately, the co-transplantation results of MCs and BMSCs (25% MCs and 75% BMSCs) demonstrated a strong chondroinductive ability of MCs to promote stable ectopic chondrogenesis of BMSCs in subcutaneous environment. Moreover, cell labeling demonstrated that BMSCs could transform into chondrocyte-like cells under the chondrogenic niche provided by co-cultured MCs. Most importantly, a human-ear-shaped cartilaginous tissue with delicate structure and proper elasticity was successfully constructed by seeding the mixed cells (MCs and BMSCs) into the pre-shaped biodegradable ear-scaffold followed by 12 weeks of subcutaneous implantation in nude mouse. These results may provide a promising strategy to construct stable ectopic cartilage with MCs and stem cells (BMSCs) for autologous external ear reconstruction.     

Co-occurrence in body site of malformations and cancer

In many malformation syndromes benign and malignant tumours develop more frequently than in the general population. Malformations result from an abnormal intrinsic developmental process. It can be hypothesised that disturbed regulation of cell growth as can become evident by the presence of benign and malignant tumours, which will occur at the same site of a malformation or at other sites at which the gene involved in the malformation is functioning.The present study aimed to compare the localisation of malignant and benign tumours to the localisation of major and minor characteristics of syndromes that have either of two malformations, i.e. microtia and hypospadias. To eliminate co-occurrence of a malformation syndrome and tumours by chance we confined evaluations to syndromes which have been described in >100 individuals. We identified 11 syndromes associated with microtia and 26 syndromes associated with hypospadias, for which co-localisation of (benign and malignant) tumours with (major and minor) syndrome characteristics was determined. In both groups of syndromes tumours were found to be localised at the same body site as the major and minor characteristics of the syndromes in two-third of the tumours. There was no significant difference in co-occurrence in site between benign and malignant tumours.We conclude that in two groups of malformation syndromes which go along with a different core malformation, benign and malignant tumours co-localise with the core malformation or with other sites at which the gene involved is functioning. This adds further proof that tumours in malformation syndromes can usually be explained by abnormal functioning of the same gene that has caused the malformation syndrome.     

集束化护理提高小耳畸形患者再造耳清洁度的效果观察

目的 探索集束化护理提高小耳畸形清洁度的临床效果.方法 2019年1月成立品管圈小组,通过对再造耳清洁度的现况调查,分析影响清洁度的因素,设定目标、拟定对策并实施.结果 开展品管圈活动后,再造耳的清洁度得分由53分上升到81分,目标达成率为105％,进步率为53％.小组成员从解决问题的能力、积极性、品管圈手法掌握程度、...